Page last updated: 2024-08-18

thiophenes and Hyperuricemia

thiophenes has been researched along with Hyperuricemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, WX; Kumagai, T; Shibata, S; Tamura, Y; Uchida, S	1
Dhaun, N; Goddard, J; Johnston, NR; Webb, DJ	1
Bernaud, C; Chanard, J; Hurault de Ligny, B; Lavaud, S; Moulin, B; Toupance, O	1

Reviews

1 review(s) available for thiophenes and Hyperuricemia

Article	Year
Time to Target Uric Acid to Retard Chronic Kidney Disease Progression. Contributions to nephrology, 2018, Volume: 192 Topics: Allopurinol; Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily G, Member 2; Disease Progression; Enzyme Inhibitors; Febuxostat; Glucosides; Gout Suppressants; Humans; Hyperuricemia; Monosaccharide Transport Proteins; Nitriles; Oxidative Stress; Pyridines; Renal Insufficiency, Chronic; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Uric Acid; Xanthine Oxidase	2018

Article

Year

Time to Target Uric Acid to Retard Chronic Kidney Disease Progression.

Contributions to nephrology, 2018, Volume: 192

Topics: Allopurinol; Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily G, Member 2; Disease Progression; Enzyme Inhibitors; Febuxostat; Glucosides; Gout Suppressants; Humans; Hyperuricemia; Monosaccharide Transport Proteins; Nitriles; Oxidative Stress; Pyridines; Renal Insufficiency, Chronic; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Uric Acid; Xanthine Oxidase

2018

Trials

2 trial(s) available for thiophenes and Hyperuricemia

Article	Year
Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease. Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:2 Topics: Cross-Over Studies; Double-Blind Method; Endothelin A Receptor Antagonists; Hypertension; Hyperuricemia; Isoxazoles; Kidney Failure, Chronic; Thiophenes; Treatment Outcome; Uric Acid	2011
Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:10 Topics: Adult; Amlodipine; Cyclosporine; Double-Blind Method; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hypertension; Hyperuricemia; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Propanolamines; Reference Values; Risk Assessment; Thiophenes; Transplantation Immunology; Treatment Outcome; Vasodilator Agents	2003

Article

Year

Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.

Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:2

Topics: Cross-Over Studies; Double-Blind Method; Endothelin A Receptor Antagonists; Hypertension; Hyperuricemia; Isoxazoles; Kidney Failure, Chronic; Thiophenes; Treatment Outcome; Uric Acid

2011

Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:10

Topics: Adult; Amlodipine; Cyclosporine; Double-Blind Method; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hypertension; Hyperuricemia; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Propanolamines; Reference Values; Risk Assessment; Thiophenes; Transplantation Immunology; Treatment Outcome; Vasodilator Agents

2003